Century Therapeutics Statistics
Total Valuation
IPSC has a market cap or net worth of $43.17 million. The enterprise value is -$92.29 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IPSC has 86.05 million shares outstanding. The number of shares has increased by 32.60% in one year.
| Current Share Class | 86.05M |
| Shares Outstanding | 86.05M |
| Shares Change (YoY) | +32.60% |
| Shares Change (QoQ) | +0.84% |
| Owned by Insiders (%) | 4.46% |
| Owned by Institutions (%) | 33.90% |
| Float | 39.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.99 |
| Forward PS | 0.77 |
| PB Ratio | 0.27 |
| P/TBV Ratio | 0.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.50, with a Debt / Equity ratio of 0.33.
| Current Ratio | 1.50 |
| Quick Ratio | 1.47 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -73.14% and return on invested capital (ROIC) is -37.70%.
| Return on Equity (ROE) | -73.14% |
| Return on Assets (ROA) | -23.67% |
| Return on Invested Capital (ROIC) | -37.70% |
| Return on Capital Employed (ROCE) | -60.49% |
| Revenue Per Employee | $43,927 |
| Profits Per Employee | -$843,773 |
| Employee Count | 150 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IPSC has paid $1.79 million in taxes.
| Income Tax | 1.79M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.10% in the last 52 weeks. The beta is 1.84, so IPSC's price volatility has been higher than the market average.
| Beta (5Y) | 1.84 |
| 52-Week Price Change | -83.10% |
| 50-Day Moving Average | 0.58 |
| 200-Day Moving Average | 1.26 |
| Relative Strength Index (RSI) | 45.28 |
| Average Volume (20 Days) | 656,844 |
Short Selling Information
The latest short interest is 3.49 million, so 4.06% of the outstanding shares have been sold short.
| Short Interest | 3.49M |
| Short Previous Month | 3.13M |
| Short % of Shares Out | 4.06% |
| Short % of Float | 8.78% |
| Short Ratio (days to cover) | 6.53 |
Income Statement
In the last 12 months, IPSC had revenue of $6.59 million and -$126.57 million in losses. Loss per share was -$1.61.
| Revenue | 6.59M |
| Gross Profit | -100.66M |
| Operating Income | -135.17M |
| Pretax Income | -131.64M |
| Net Income | -126.57M |
| EBITDA | -121.86M |
| EBIT | -135.17M |
| Loss Per Share | -$1.61 |
Full Income StatementBalance Sheet
The company has $189.29 million in cash and $53.83 million in debt, giving a net cash position of $135.46 million or $1.57 per share.
| Cash & Cash Equivalents | 189.29M |
| Total Debt | 53.83M |
| Net Cash | 135.46M |
| Net Cash Per Share | $1.57 |
| Equity (Book Value) | 161.36M |
| Book Value Per Share | 1.88 |
| Working Capital | 64.27M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$110.14 million and capital expenditures -$154,000, giving a free cash flow of -$110.29 million.
| Operating Cash Flow | -110.14M |
| Capital Expenditures | -154,000 |
| Free Cash Flow | -110.29M |
| FCF Per Share | -$1.28 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -2,051.39% |
| Pretax Margin | -1,893.70% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IPSC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.60% |
| Shareholder Yield | -32.60% |
| Earnings Yield | -293.19% |
| FCF Yield | -255.48% |
Analyst Forecast
The average price target for IPSC is $3.67, which is 633.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.67 |
| Price Target Difference | 633.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | -34.99% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IPSC has an Altman Z-Score of -3.52 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.52 |
| Piotroski F-Score | 3 |